By Rob Rogers, MD, Precision Medicine and Brain Health, Peak Launch
Precision medicine is not hormone therapy with a better name, it is not a longer lab panel, and it is not a shelf of supplements. It is a system for figuring out which parts of your biology are actually limiting your energy, focus, strength, and recovery, and then deciding what to do about them in the right order.
The tools are ordinary. The decision-making is what separates it from everything else.
That distinction is the entire argument, and it is the part most people miss, including a lot of physicians.
Why Does Your Doctor Say Everything Looks Fine When You Know It Isn’t?
You are 49. You run a company. You sleep six and a half hours, travel most months, train four days a week when the calendar allows it, and you eat better than most people you know. But your afternoons have gotten heavier. Your recall for names is a half-second slower than it used to be. You need two days to recover from a workout that used to cost you one.
So you go in for the annual physical. Fifteen minutes, a standard panel, and a verdict: everything looks normal.
Both things are true. Your labs are normal, and you feel worse than you did three years ago. Traditional medicine is not failing you out of negligence. It is doing exactly what it was designed to do, which is find disease and treat it. It was never built to answer the question you are actually asking, which is why a body that used to keep up with you no longer does.
Normal is a wide range built to catch illness. It is a very low bar for someone trying to operate at a high level.
What Is Precision Medicine, Exactly?
Precision medicine is a proactive, data-driven model of care that evaluates the whole system, metabolism, brain health, inflammation, recovery, hormone signaling, and genetics, to identify the specific constraints limiting how a person performs, then builds and adjusts an individual strategy around them.
At Peak Launch we work in a narrower version of this called Precision Performance Medicine, which applies the same rigor to real-world capacity: energy, focus, strength, resilience, and leadership capacity today, with long-term risk reduction as the downstream benefit.
The framework is simple to say and hard to do well. Test. Design. Track.
Where this gets misunderstood is that people hear about the tools and assume the tools are the model. They are not. Here is what that mistake sounds like in practice.
Is Precision Medicine Just Hormone Therapy?
This is the most common version, and it is the most damaging, because it is close enough to true that it stops the conversation.
Hormones matter enormously. Testosterone, estrogen, thyroid, insulin, cortisol, and DHEA all shape energy, cognition, body composition, and drive. Anyone who tells you otherwise is not paying attention.
But a hormone level is a readout, not a diagnosis. A low hormone level has a cause. Sometimes that cause is primary and the right answer is to replace what is missing. Often the reason is upstream: chronically short sleep, visceral fat driving aromatization, unmanaged stress load, poor metabolic health, or a thyroid problem nobody looked for.
Replace the number without addressing what pushed it down and you get a few good months followed by a slow return to where you started, only now with a prescription you did not need.
This is why a piece of content like this one should make you more skeptical of a clinic that leads with testosterone, not less. If the first conversation is about a script, the system behind it is thin.
The question precision medicine asks is not “what is the level.” It is “why is this system producing this number, and is that the constraint worth solving first.”
Is Precision Medicine Just Running More Labs?
More data is easy. Better decisions are hard.
Advanced testing earns its place when a specific result would change what you do. Two examples make the point.
Lipoprotein(a), or Lp(a), is a genetically determined particle that raises cardiovascular risk independently of LDL cholesterol. The 2022 European Atherosclerosis Society consensus statement estimates it affects roughly one in five people worldwide, and lifestyle changes barely move it. It is a one-time test, and most standard panels never order it.
If yours is high, it does not change your workout, it changes how aggressively you and your physician manage every other lever you can control, and it tells your children something they should know.
Apolipoprotein B is a second example. It counts the atherogenic particles in your blood rather than estimating the cholesterol inside them, and the 2019 ESC/EAS dyslipidaemia guidelines concluded it is a more accurate marker of cardiovascular risk than LDL-C alone. It costs almost nothing to add. Most physicals still leave it off.
Neither of those tests is exotic. Both change decisions. That is the standard.
Contrast that with ordering two hundred markers because the panel exists. Every result carries noise, and noise generates action. Chasing a mildly abnormal value that means nothing is not thoroughness, it is a distraction with a copay. You cannot fix what you cannot see, but seeing everything is not the same as seeing what matters.
Is Precision Medicine Just A Supplement Stack?
Supplements are the easiest thing to sell and the least likely thing to be the answer.
They have real uses. Correcting a documented deficiency works. Targeted support for a specific pathway can help. But no supplement compensates for five hours of sleep, unmanaged cortisol, insulin resistance, or a training program that is not happening.
The tell is sequencing. When a plan opens with a stack of twelve bottles before anyone has looked at sleep architecture, metabolic markers, or recovery data, that is not precision. That is retail.
Dr. Gapin puts it this way: you have to bake the cake before you put the frosting on it. Foundations first. The advanced tools work far better on top of a system that is already functioning.
What Does Precision Medicine Actually Look At?
Fewer things than the marketing suggests, and in a deliberate order.
Metabolic health. Fasting insulin, glucose stability, ApoB, Lp(a), and how well your body switches between fuel sources. Metabolic dysfunction shows up in your energy and focus years before it shows up on a diabetes screen.
Recovery and stress physiology. Deep sleep, heart rate variability, autonomic balance, and inflammatory tone. This is usually where high performers are quietly losing the most ground, and it is the area they are least willing to look at.
Body composition and strength. Grip strength turns out to be one of the more reliable predictors of long-term outcomes we have.
A meta-analysis of 42 prospective studies covering more than three million people found that people in the lowest grip strength category had a substantially higher risk of death from any cause than those in the highest, and the large PURE study reported the same pattern across dozens of countries.
Worth noting: several of these studies found that strength predicted outcomes better than muscle mass did. Building strength is not vanity. It is a hedge on your next thirty years.
Brain health. This is the newest and most interesting area. Blood-based markers such as p-tau217, GFAP, and NfL have changed what is possible in evaluating cognitive symptoms. A large multi-site study published in Nature Medicine found plasma p-tau217 identified Alzheimer’s pathology with roughly 85 to 91 percent accuracy across primary and specialty care settings.
That last one deserves a caveat, and here is where most content on this subject gets it wrong.
What Precision Medicine Will Not Promise You
Those brain biomarkers were validated in people who already had cognitive symptoms. They are triage tools that help clinicians decide who needs further evaluation. They are not a screening test for a symptom-free 50-year-old, and any clinic marketing them that way is ahead of the evidence.
That kind of honesty is not a weakness in the model. It is the model. Precision medicine done properly tells you what the data can support and what it cannot, then makes a decision anyway, because you still have to live your life while the science catches up.
It also will not promise you a reversal, a cure, or a guaranteed outcome. What a good system does is narrow the guesswork, prioritize the few changes that will move the most, and adapt when your travel schedule, your stress load, or your body changes.
Static plans fail because life is not static.
Normal Is a Low Bar. What Is Actually Holding You Back?
The next step is a free Strategy Call. It is a straight conversation about the gap between how you are performing and what you know you are capable of, and what your data would need to show to close it.
Frequently Asked Questions
Precision medicine is an approach to care that uses detailed individual data, including advanced lab work, genetics, and wearable data, to identify the specific causes of a person’s symptoms rather than treating symptoms generically. The goal is to find and address the underlying constraint, not to manage the complaint.
They overlap but are not identical. Both look upstream for root causes. Precision medicine places more weight on objective measurement, validated biomarkers, and continuous tracking of whether an intervention is actually working, and it is typically delivered under physician oversight.
No. Hormone optimization is one possible tool among many, and it is often not the first or most important lever. A proper evaluation may point to sleep, metabolic health, stress physiology, or something else entirely.
Generally no. Most insurance is structured to reimburse the diagnosis and treatment of disease, not proactive optimization in people who are not sick. Some individual lab tests may be covered. Programs like ours are typically paid directly.
An executive physical is a snapshot. You get a comprehensive workup once a year and a report. Precision Performance Medicine is continuous. The testing is the starting point, followed by a designed strategy, ongoing tracking, and adjustments as your data and your life change.
It fits people who feel a gap between how they are performing and what they know they are capable of, who want an objective explanation rather than reassurance, and who are willing to act on what the data shows.
Sources
- Palmqvist S, et al. Plasma phospho-tau217 for Alzheimer’s disease diagnosis in primary and secondary care using a fully automated platform. Nature Medicine, 2025. https://www.nature.com
- Kronenberg F, Mora S, Stroes ESG, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. European Heart Journal, 2022;43:3925-3946. https://eas-society.org
- Leong DP, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. The Lancet, 2015. https://www.thelancet.com
- Wu Y, et al. Association of grip strength with risk of all-cause mortality, cardiovascular diseases, and cancer in community-dwelling populations: a meta-analysis of prospective cohort studies. JAMDA, 2017. https://pubmed.ncbi.nlm.nih.gov
- Sniderman AD, et al. ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk. Journal of Clinical Lipidology, 2025. https://www.sciencedirect.com/
This article is for informational purposes and is not medical advice. It does not establish a physician-patient relationship. Talk with your own physician before making changes to your care, medications, or supplements.
